C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/17/2002	US20020152482 Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hypothermia, and colitis
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020152480 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation
10/17/2002	US20020152479 Car modulators: screening and treatment of hypercholesterolemia
10/17/2002	US20020151709 Obtained from mutagenic strains of Bacillus thuringiensis encoding endotoxins
10/17/2002	US20020151706 Antiinflammatory agents
10/17/2002	US20020151703 Process for producing microbial transglutaminase
10/17/2002	US20020151699 Transgenic; gene expression; cloning; isolation of ricinoleic acid from oleic acid in developing endosperm of castor
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151696 Detecting/diagnosing and treating metallopeptidase-related disorders; detecting/diagnosing human ribosyltransferase-related disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151694 Release of intracellular material
10/17/2002	US20020151691 Class II transactivators (CIITA); major histocompatability complex; gene expression inhibition; cloning; vaccines; transcriptional promoter activity
10/17/2002	US20020151684 Fusion protein and uses thereof
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151679 Peptide for use in the treatment of infections, viral and cancer diseases
10/17/2002	US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151518 Oligonucleotide mediated specific sytokine induction and reduction of tumor growth in a mammal
10/17/2002	US20020151517 Administering to the mammal nucleosomes(a complex of DNA and histones) that elicit the production of antinuclear autoantibodies sufficient to inhibit neoplastic cell growth
10/17/2002	US20020151516 Carrier:nucleic acids complexes containing nucleic acids encoding anti-angiogenic peptides and their use in gene therapy
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151513 Localized oligonucleotide therapy for preventing restenosis
10/17/2002	US20020151512 Used to diagnose or treat cancer, restenosis, a disease caused by a virus, a disease affected by integrins or cell-cell adhesion receptor or a disease triggered by diffusible factors
10/17/2002	US20020151511 Antisense oligonucleotide modulation of human MDM2 expression
10/17/2002	US20020151509 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151496 Treatment of spinal cord damage, spinal cord trauma, neuronal tissue damage produced by ischemic attack
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151486 Stimulating and modulating bone cell differentiation and bone formation; bone disorders including osteopetrosis and osteoporosis; genetic engineeing; gene therapy;
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151482 Administering to a bird or mammal a PRG-B polypeptide as an angiogenesis inhibitor; antitumor, -carcinogenic, -neoplastic and -arthritic agents; diabetic retinopathy; cancer of the lung, breast, or prostate gland; gene therapy
10/17/2002	US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151472 Trefoil factor (TFF) peptides (tricyclic peptides, e.g., TFF2 peptides), for increasing the viscosity of mucus layers; used for treating damaged or abnormal mucus layers, e.g. in the gastrointestinal tract, respiratory/urogential systems, eyes
10/17/2002	US20020151469 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151468 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151464 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
10/17/2002	US20020151463 Gene and polypeptide compositions in which expression of the agouti gene correlates with the development of insulin independent diabetes, hyperamylinemia, neoplasms and obesity
10/17/2002	US20020151460 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/17/2002	US20020151450 Obtainable from stachybotrys with specific amino acid sequence are useful in modifying the color associated with dyes and colored compounds
10/17/2002	US20020151077 Apparatus for use in the generation of microarray for use in the detection of prefeentialparticles in sample
10/17/2002	US20020151073 Transcription factor
10/17/2002	US20020151072 Chimeric mutational vectors
10/17/2002	US20020151071 Recovering mutant bacillus; obtain bacillus, transform with vector containing protein which deactivates hemolysin, recover bacillus with deactivated hemolysin activity, propagate
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151069 Expression vector for use as gene transfer tool in genetic engineering
10/17/2002	US20020151068 Compositions and methods for the diagnosis and treatment of organophosphate toxicity
10/17/2002	US20020151067 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases
10/17/2002	US20020151064 Regulation of CCR3 expression
10/17/2002	US20020151063 Controlling apoptosis in cells; obtain cells, incubate with modulator, monitor transcriptional activity and apoptosis
10/17/2002	US20020151062 Monitoring efficiency of peptiod to transfect cell; obtain cell, incubate with oligonucleotide and peptiod, monitor efficiency of transfection of oligonucleotide
10/17/2002	US20020151061 Transform cells; obtain nutrient broth, incubate with binding polypeptide, transforming cells, evaluate cells for transformation activity
10/17/2002	US20020151059 Generating genetically engineered cells; obtain cells, incubate with nucleotide sequences, transform cells, detect and recover cell containing exogenous nucleotide sequences
10/17/2002	US20020151058 Vector construction by host cell-mediated recombination
10/17/2002	US20020151053 Generation of preferential cells in culture; generate nutrient broth, inoculate with cells, propagate, recover preferential cells
10/17/2002	US20020151051 Compositions and methods for isolating genes comprising subcellular localization sequences
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151048 Process for the scaleable purification of plasmid DNA
10/17/2002	US20020151047 Nucleotide sequences coding polypeptide for use in human therapeutics, diagnostics and pharmocology
10/17/2002	US20020151036 Process for producing cytidine diphosphate choline
10/17/2002	US20020151035 Nucleotide sequences coding enzymatic polypeptide for use in generation of medicines
10/17/2002	US20020151034 Stable zymomonas mobilis xylose and arabinose fermenting strains
10/17/2002	US20020151033 Viral vector for use as tool in genetic engineering
10/17/2002	US20020151032 Generation of preferential viral vector; obtain cell, incubate with viral nucleotide sequences, propagate, recover nucleotide sequences
10/17/2002	US20020151027 Viral fiber protein for use in the treatment of viral diseases
10/17/2002	US20020151026 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of tissue injuries
10/17/2002	US20020151025 Human TSC403 gene and human ING1L gene
10/17/2002	US20020151024 DNA encoding mammalian phosphodiesterases
10/17/2002	US20020151023 GMP synthetase and gene coding for the same
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151019 Enzymatic polypeptide for use in the fatty acid biosynthesis in plants
10/17/2002	US20020151018 Stearoyl-CoA desaturase gene promoter
10/17/2002	US20020151017 Methods for obtaining a polynecleotide encoding a polypeptide having a rubisco activity
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020151008 Nucleotide sequences coding polypeptide for use in the prevention of bacterial infections
10/17/2002	US20020151007 Nucleotide seauemces coding enzymatic polypeptide for use in the treatment, prevention of tumor
10/17/2002	US20020151005 53070, a novel human protein kinase family member and uses thereof
10/17/2002	US20020151003 Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium
10/17/2002	US20020151002 Sinapoylglucose:malate sinapoyltransferase form malate conjugates from benozic acid glucosides
10/17/2002	US20020150999 Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria
10/17/2002	US20020150996 Functional nucleic acid probes and uses thereof
10/17/2002	US20020150995 Methods for producing sialyloligosaccharides in a dairy source
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150992 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150988 Nucleotide sequences coding polypeptide for use in the forensic analysis and diagnosis and treatment of genetic disorders
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150983 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
10/17/2002	US20020150982 Generating mutant desaturase; obtain nucleotide sequence coding desaturase, mutate, obtain cell, transform with mutant sequences, express mutant nucleotide sequences in cell, recover mutant protein
10/17/2002	US20020150981 Methods for producing highly phosphorylated lysosomal hydrolases
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders

1 ... 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 ... 4023